Gene therapy specific for ovarian cancer by IAI.3B promoter-driven oncolytic adenovirus

被引:0
|
作者
Hamada, Katsuyuki [1 ]
机构
[1] Ehime Univ, Matsuyama, Ehime, Japan
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
3006
引用
收藏
页数:1
相关论文
共 50 条
  • [21] Adenovirus gene therapy for ovarian cancer
    Russell, W
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2002, 94 (10): : 706 - 707
  • [22] Biosilicified oncolytic adenovirus for cancer viral gene therapy
    Kong, Hao
    Zhao, Ruibo
    Zhang, Quan
    Iqbal, Muhammed Zubair
    Lu, Jiaju
    Zhao, Qingwei
    Luo, Dandan
    Feng, Cui
    Zhang, Kangjian
    Liu, Xinyuan
    Kong, Xiangdong
    BIOMATERIALS SCIENCE, 2020, 8 (19) : 5317 - 5328
  • [23] Targeted Cancer Gene Therapy Using Oncolytic Adenovirus
    Yoo, Ji Young
    Yun, Chae-Ok
    ICCB 2008: PROCEEDINGS OF THE 9TH INTERNATIONAL CONGRESS ON CELL BIOLOGY, 2008, : 7 - 18
  • [24] Improved nonviral cancer suicide gene therapy using survivin promoter-driven mutant Bax
    H Garg
    R Salcedo
    G Trinchieri
    R Blumenthal
    Cancer Gene Therapy, 2010, 17 : 155 - 163
  • [25] Targeted gene therapy of ovarian cancer using an ovarian-specific promoter
    Bao, RD
    Selvakumaran, M
    Hamilton, TC
    GYNECOLOGIC ONCOLOGY, 2002, 84 (02) : 228 - 234
  • [26] Improved nonviral cancer suicide gene therapy using survivin promoter-driven mutant Bax
    Garg, H.
    Salcedo, R.
    Trinchieri, G.
    Blumenthal, R.
    CANCER GENE THERAPY, 2010, 17 (03) : 155 - 163
  • [27] Evaluation of CMV promoter-driven transgene expression for ocular gene therapy
    Aguilar, HH
    Gonzales, JC
    von Seggern, D
    Friedlander, M
    Nemerow, G
    Ghazal, P
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 1999, 40 (04) : S575 - S575
  • [28] Pancreatic Cancer Gene Therapy with Liposome-Processed Midkine Gene Promoter-Introduced Oncolytic Adenovirus
    Okada, Rei
    Hamada, Katsuyuki
    Yamakawa, Teruki
    Kajiwara, Youji
    Shimada, Hideaki
    MOLECULAR THERAPY, 2023, 31 (04) : 715 - 715
  • [29] Oncolytic Adenovirus Driven by the SCG3 Promoter and ASH1 Enhancer for Neuroblastoma Therapy
    Jin, C. J.
    Yu, D. Y.
    Leja, J. L.
    Nilsson, B. N.
    Essand, M. E.
    HUMAN GENE THERAPY, 2011, 22 (10) : A115 - A115
  • [30] Tumor-specific imaging through progression elevated gene-3 promoter-driven gene expression
    Bhang, Hyo-eun C.
    Gabrielson, Kathleen L.
    Laterra, John
    Fisher, Paul B.
    Pomper, Martin G.
    NATURE MEDICINE, 2011, 17 (01) : 123 - U302